Ace-Inhibition with Quinapril Modulates the Nitric Oxide Pathway in Normotensive Rats
- 1 March 2001
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 33 (3) , 395-403
- https://doi.org/10.1006/jmcc.2000.1311
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Enhanced angiotensin-converting enzyme activity and impaired endothelium-dependent vasodilation in aortae from hypertensive rats: evidence for a causal linkClinical Science, 1999
- Endothelial Dysfunction: From Physiology to TherapyJournal of Molecular and Cellular Cardiology, 1999
- Endothelial Dysfunction in Human DiseaseJournal of Molecular and Cellular Cardiology, 1999
- Differential Effects of Quinaprilat and Enalaprilat on Endothelial Function of Conduit Arteries in Patients With Chronic Heart FailureCirculation, 1998
- Alterations of Nitric Oxide Synthase Expression With Aging and Hypertension in RatsHypertension, 1998
- Role of Bradykinin in Mediating Vascular Effects of Angiotensin-Converting Enzyme Inhibitors in HumansCirculation, 1997
- Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery DiseaseCirculation, 1996
- Nitric oxide synthases in the cardiovascular systemTrends in Cardiovascular Medicine, 1993
- Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proceedings of the National Academy of Sciences, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987